nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Electrolyte imbalance—Vinorelbine—ovarian cancer	0.0271	0.0279	CcSEcCtD
Methyclothiazide—Respiratory distress—Melphalan—ovarian cancer	0.0204	0.021	CcSEcCtD
Methyclothiazide—Electrolyte imbalance—Paclitaxel—ovarian cancer	0.0182	0.0187	CcSEcCtD
Methyclothiazide—Vertigo—Altretamine—ovarian cancer	0.0164	0.0169	CcSEcCtD
Methyclothiazide—Leukopenia—Altretamine—ovarian cancer	0.0164	0.0168	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Chlorambucil—ovarian cancer	0.016	0.0165	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Chlorambucil—ovarian cancer	0.0151	0.0156	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Altretamine—ovarian cancer	0.0146	0.015	CcSEcCtD
Methyclothiazide—Anorexia—Altretamine—ovarian cancer	0.0142	0.0146	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Melphalan—ovarian cancer	0.014	0.0144	CcSEcCtD
Methyclothiazide—Vasculitis—Melphalan—ovarian cancer	0.0133	0.0137	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Melphalan—ovarian cancer	0.0132	0.0136	CcSEcCtD
Methyclothiazide—Decreased appetite—Altretamine—ovarian cancer	0.013	0.0133	CcSEcCtD
Methyclothiazide—Respiratory distress—Paclitaxel—ovarian cancer	0.012	0.0123	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.0119	0.0123	CcSEcCtD
Methyclothiazide—Asthenia—Altretamine—ovarian cancer	0.0107	0.011	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Vinorelbine—ovarian cancer	0.0106	0.0109	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Melphalan—ovarian cancer	0.0104	0.0107	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Vinorelbine—ovarian cancer	0.0101	0.0104	CcSEcCtD
Methyclothiazide—Dizziness—Altretamine—ovarian cancer	0.00987	0.0101	CcSEcCtD
Methyclothiazide—Vomiting—Altretamine—ovarian cancer	0.00949	0.00976	CcSEcCtD
Methyclothiazide—Nausea—Altretamine—ovarian cancer	0.00886	0.00912	CcSEcCtD
Methyclothiazide—Cramp muscle—Topotecan—ovarian cancer	0.00865	0.0089	CcSEcCtD
Methyclothiazide—Pneumonia—Chlorambucil—ovarian cancer	0.00836	0.0086	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00824	0.00848	CcSEcCtD
Methyclothiazide—Body temperature increased—Carboplatin—ovarian cancer	0.00815	0.00838	CcSEcCtD
Methyclothiazide—Jaundice—Chlorambucil—ovarian cancer	0.0081	0.00834	CcSEcCtD
Methyclothiazide—Pneumonia—Topotecan—ovarian cancer	0.00744	0.00766	CcSEcCtD
Methyclothiazide—Jaundice—Melphalan—ovarian cancer	0.00706	0.00727	CcSEcCtD
Methyclothiazide—Erythema multiforme—Chlorambucil—ovarian cancer	0.00706	0.00726	CcSEcCtD
Methyclothiazide—Pancreatitis—Vinorelbine—ovarian cancer	0.00696	0.00716	CcSEcCtD
Methyclothiazide—Pneumonia—Vinorelbine—ovarian cancer	0.00637	0.00655	CcSEcCtD
Methyclothiazide—Hypercalcaemia—Epirubicin—ovarian cancer	0.00626	0.00644	CcSEcCtD
Methyclothiazide—Agitation—Chlorambucil—ovarian cancer	0.00597	0.00614	CcSEcCtD
Methyclothiazide—Agranulocytosis—Vinorelbine—ovarian cancer	0.00591	0.00608	CcSEcCtD
Methyclothiazide—Leukopenia—Chlorambucil—ovarian cancer	0.00582	0.00598	CcSEcCtD
Methyclothiazide—Hypercalcaemia—Doxorubicin—ovarian cancer	0.0058	0.00596	CcSEcCtD
Methyclothiazide—Malnutrition—Topotecan—ovarian cancer	0.00578	0.00595	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Docetaxel—ovarian cancer	0.00574	0.00591	CcSEcCtD
Methyclothiazide—Muscle spasms—Topotecan—ovarian cancer	0.00556	0.00572	CcSEcCtD
Methyclothiazide—Glycosuria—Epirubicin—ovarian cancer	0.00537	0.00553	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00519	0.00534	CcSEcCtD
Methyclothiazide—Leukopenia—Topotecan—ovarian cancer	0.00518	0.00533	CcSEcCtD
Methyclothiazide—Leukopenia—Melphalan—ovarian cancer	0.00507	0.00521	CcSEcCtD
Methyclothiazide—Anorexia—Chlorambucil—ovarian cancer	0.00505	0.0052	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00505	0.00519	CcSEcCtD
Methyclothiazide—Cramp muscle—Paclitaxel—ovarian cancer	0.00498	0.00512	CcSEcCtD
Methyclothiazide—Glycosuria—Doxorubicin—ovarian cancer	0.00497	0.00511	CcSEcCtD
Methyclothiazide—Malnutrition—Vinorelbine—ovarian cancer	0.00495	0.00509	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Topotecan—ovarian cancer	0.00472	0.00486	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Epirubicin—ovarian cancer	0.00469	0.00483	CcSEcCtD
Methyclothiazide—Pancreatitis—Paclitaxel—ovarian cancer	0.00468	0.00482	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Melphalan—ovarian cancer	0.00462	0.00475	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Topotecan—ovarian cancer	0.00462	0.00475	CcSEcCtD
Methyclothiazide—Decreased appetite—Chlorambucil—ovarian cancer	0.00461	0.00474	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Melphalan—ovarian cancer	0.00453	0.00466	CcSEcCtD
Methyclothiazide—Anorexia—Topotecan—ovarian cancer	0.0045	0.00463	CcSEcCtD
Methyclothiazide—Vertigo—Vinorelbine—ovarian cancer	0.00444	0.00457	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Epirubicin—ovarian cancer	0.00443	0.00456	CcSEcCtD
Methyclothiazide—Leukopenia—Vinorelbine—ovarian cancer	0.00443	0.00456	CcSEcCtD
Methyclothiazide—Anorexia—Melphalan—ovarian cancer	0.00441	0.00453	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00436	0.00448	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Doxorubicin—ovarian cancer	0.00434	0.00447	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00431	0.00443	CcSEcCtD
Methyclothiazide—Pneumonia—Paclitaxel—ovarian cancer	0.00428	0.00441	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Docetaxel—ovarian cancer	0.00428	0.0044	CcSEcCtD
Methyclothiazide—Paraesthesia—Topotecan—ovarian cancer	0.00424	0.00436	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00422	0.00434	CcSEcCtD
Methyclothiazide—Cramp muscle—Docetaxel—ovarian cancer	0.00422	0.00434	CcSEcCtD
Methyclothiazide—Urticaria—Chlorambucil—ovarian cancer	0.00421	0.00433	CcSEcCtD
Methyclothiazide—Body temperature increased—Chlorambucil—ovarian cancer	0.00419	0.00431	CcSEcCtD
Methyclothiazide—Paraesthesia—Melphalan—ovarian cancer	0.00415	0.00427	CcSEcCtD
Methyclothiazide—Decreased appetite—Topotecan—ovarian cancer	0.0041	0.00422	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Doxorubicin—ovarian cancer	0.0041	0.00422	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Epirubicin—ovarian cancer	0.00409	0.0042	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00404	0.00415	CcSEcCtD
Methyclothiazide—Constipation—Topotecan—ovarian cancer	0.00404	0.00415	CcSEcCtD
Methyclothiazide—Decreased appetite—Melphalan—ovarian cancer	0.00402	0.00413	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00395	0.00407	CcSEcCtD
Methyclothiazide—Hypersensitivity—Chlorambucil—ovarian cancer	0.00391	0.00402	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Epirubicin—ovarian cancer	0.00387	0.00398	CcSEcCtD
Methyclothiazide—Anorexia—Vinorelbine—ovarian cancer	0.00385	0.00396	CcSEcCtD
Methyclothiazide—Asthenia—Chlorambucil—ovarian cancer	0.0038	0.00391	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00378	0.00389	CcSEcCtD
Methyclothiazide—Urticaria—Topotecan—ovarian cancer	0.00375	0.00386	CcSEcCtD
Methyclothiazide—Body temperature increased—Topotecan—ovarian cancer	0.00373	0.00384	CcSEcCtD
Methyclothiazide—Urticaria—Melphalan—ovarian cancer	0.00367	0.00378	CcSEcCtD
Methyclothiazide—Pneumonia—Docetaxel—ovarian cancer	0.00363	0.00373	CcSEcCtD
Methyclothiazide—Diarrhoea—Chlorambucil—ovarian cancer	0.00363	0.00373	CcSEcCtD
Methyclothiazide—Paraesthesia—Vinorelbine—ovarian cancer	0.00363	0.00373	CcSEcCtD
Methyclothiazide—Erythema multiforme—Paclitaxel—ovarian cancer	0.00361	0.00372	CcSEcCtD
Methyclothiazide—Photosensitivity—Epirubicin—ovarian cancer	0.0036	0.0037	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00358	0.00369	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00358	0.00368	CcSEcCtD
Methyclothiazide—Vascular purpura—Epirubicin—ovarian cancer	0.00353	0.00363	CcSEcCtD
Methyclothiazide—Jaundice—Docetaxel—ovarian cancer	0.00352	0.00362	CcSEcCtD
Methyclothiazide—Decreased appetite—Vinorelbine—ovarian cancer	0.00351	0.00361	CcSEcCtD
Methyclothiazide—Hypersensitivity—Topotecan—ovarian cancer	0.00348	0.00358	CcSEcCtD
Methyclothiazide—Constipation—Vinorelbine—ovarian cancer	0.00345	0.00355	CcSEcCtD
Methyclothiazide—Hypersensitivity—Melphalan—ovarian cancer	0.00341	0.0035	CcSEcCtD
Methyclothiazide—Asthenia—Topotecan—ovarian cancer	0.00339	0.00348	CcSEcCtD
Methyclothiazide—Vomiting—Chlorambucil—ovarian cancer	0.00337	0.00347	CcSEcCtD
Methyclothiazide—Agranulocytosis—Docetaxel—ovarian cancer	0.00337	0.00347	CcSEcCtD
Methyclothiazide—Photosensitivity—Doxorubicin—ovarian cancer	0.00333	0.00342	CcSEcCtD
Methyclothiazide—Malnutrition—Paclitaxel—ovarian cancer	0.00333	0.00342	CcSEcCtD
Methyclothiazide—Asthenia—Melphalan—ovarian cancer	0.00332	0.00341	CcSEcCtD
Methyclothiazide—Purpura—Epirubicin—ovarian cancer	0.00328	0.00337	CcSEcCtD
Methyclothiazide—Vascular purpura—Doxorubicin—ovarian cancer	0.00327	0.00336	CcSEcCtD
Methyclothiazide—Diarrhoea—Topotecan—ovarian cancer	0.00323	0.00332	CcSEcCtD
Methyclothiazide—SLC12A1—epithelium—ovarian cancer	0.00322	0.115	CbGeAlD
Methyclothiazide—Urticaria—Vinorelbine—ovarian cancer	0.00321	0.0033	CcSEcCtD
Methyclothiazide—Muscle spasms—Paclitaxel—ovarian cancer	0.0032	0.00329	CcSEcCtD
Methyclothiazide—Body temperature increased—Vinorelbine—ovarian cancer	0.00319	0.00328	CcSEcCtD
Methyclothiazide—Diarrhoea—Melphalan—ovarian cancer	0.00316	0.00325	CcSEcCtD
Methyclothiazide—Nausea—Chlorambucil—ovarian cancer	0.00315	0.00324	CcSEcCtD
Methyclothiazide—Vision blurred—Paclitaxel—ovarian cancer	0.00314	0.00323	CcSEcCtD
Methyclothiazide—SLC12A3—female reproductive system—ovarian cancer	0.00313	0.112	CbGeAlD
Methyclothiazide—Dizziness—Topotecan—ovarian cancer	0.00312	0.00321	CcSEcCtD
Methyclothiazide—Erythema multiforme—Docetaxel—ovarian cancer	0.00306	0.00315	CcSEcCtD
Methyclothiazide—Agitation—Paclitaxel—ovarian cancer	0.00306	0.00315	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—ovarian cancer	0.00303	0.00312	CcSEcCtD
Methyclothiazide—Vomiting—Topotecan—ovarian cancer	0.003	0.00309	CcSEcCtD
Methyclothiazide—Vertigo—Paclitaxel—ovarian cancer	0.00299	0.00308	CcSEcCtD
Methyclothiazide—Leukopenia—Paclitaxel—ovarian cancer	0.00298	0.00306	CcSEcCtD
Methyclothiazide—Rash—Topotecan—ovarian cancer	0.00298	0.00306	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00297	0.00306	CcSEcCtD
Methyclothiazide—Dermatitis—Topotecan—ovarian cancer	0.00297	0.00306	CcSEcCtD
Methyclothiazide—Headache—Topotecan—ovarian cancer	0.00296	0.00304	CcSEcCtD
Methyclothiazide—Vomiting—Melphalan—ovarian cancer	0.00294	0.00302	CcSEcCtD
Methyclothiazide—Rash—Melphalan—ovarian cancer	0.00291	0.003	CcSEcCtD
Methyclothiazide—Dermatitis—Melphalan—ovarian cancer	0.00291	0.003	CcSEcCtD
Methyclothiazide—Asthenia—Vinorelbine—ovarian cancer	0.0029	0.00298	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00289	0.00297	CcSEcCtD
Methyclothiazide—Malnutrition—Docetaxel—ovarian cancer	0.00282	0.0029	CcSEcCtD
Methyclothiazide—Nausea—Topotecan—ovarian cancer	0.0028	0.00288	CcSEcCtD
Methyclothiazide—Diarrhoea—Vinorelbine—ovarian cancer	0.00276	0.00284	CcSEcCtD
Methyclothiazide—Nausea—Melphalan—ovarian cancer	0.00275	0.00282	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00272	0.00279	CcSEcCtD
Methyclothiazide—Muscle spasms—Docetaxel—ovarian cancer	0.00271	0.00279	CcSEcCtD
Methyclothiazide—Pancreatitis—Epirubicin—ovarian cancer	0.00268	0.00275	CcSEcCtD
Methyclothiazide—Dizziness—Vinorelbine—ovarian cancer	0.00267	0.00275	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00267	0.00275	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00266	0.00274	CcSEcCtD
Methyclothiazide—Anorexia—Paclitaxel—ovarian cancer	0.00259	0.00266	CcSEcCtD
Methyclothiazide—Vomiting—Vinorelbine—ovarian cancer	0.00257	0.00264	CcSEcCtD
Methyclothiazide—Rash—Vinorelbine—ovarian cancer	0.00255	0.00262	CcSEcCtD
Methyclothiazide—Dermatitis—Vinorelbine—ovarian cancer	0.00254	0.00262	CcSEcCtD
Methyclothiazide—Headache—Vinorelbine—ovarian cancer	0.00253	0.0026	CcSEcCtD
Methyclothiazide—Leukopenia—Docetaxel—ovarian cancer	0.00252	0.0026	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00249	0.00256	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—ovarian cancer	0.00248	0.00255	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Epirubicin—ovarian cancer	0.00246	0.00253	CcSEcCtD
Methyclothiazide—Pneumonia—Epirubicin—ovarian cancer	0.00245	0.00252	CcSEcCtD
Methyclothiazide—Paraesthesia—Paclitaxel—ovarian cancer	0.00244	0.00251	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00241	0.00248	CcSEcCtD
Methyclothiazide—Nausea—Vinorelbine—ovarian cancer	0.0024	0.00247	CcSEcCtD
Methyclothiazide—Jaundice—Epirubicin—ovarian cancer	0.00237	0.00244	CcSEcCtD
Methyclothiazide—Decreased appetite—Paclitaxel—ovarian cancer	0.00236	0.00243	CcSEcCtD
Methyclothiazide—Constipation—Paclitaxel—ovarian cancer	0.00232	0.00239	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00231	0.00237	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Docetaxel—ovarian cancer	0.0023	0.00237	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00228	0.00234	CcSEcCtD
Methyclothiazide—Agranulocytosis—Epirubicin—ovarian cancer	0.00227	0.00234	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—ovarian cancer	0.00227	0.00233	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00225	0.00232	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00223	0.0023	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—ovarian cancer	0.0022	0.00226	CcSEcCtD
Methyclothiazide—Anorexia—Docetaxel—ovarian cancer	0.00219	0.00226	CcSEcCtD
Methyclothiazide—Urticaria—Paclitaxel—ovarian cancer	0.00216	0.00222	CcSEcCtD
Methyclothiazide—Body temperature increased—Paclitaxel—ovarian cancer	0.00215	0.00221	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—ovarian cancer	0.0021	0.00216	CcSEcCtD
Methyclothiazide—Paraesthesia—Docetaxel—ovarian cancer	0.00207	0.00213	CcSEcCtD
Methyclothiazide—Erythema multiforme—Epirubicin—ovarian cancer	0.00207	0.00213	CcSEcCtD
Methyclothiazide—Decreased appetite—Docetaxel—ovarian cancer	0.002	0.00206	CcSEcCtD
Methyclothiazide—Hypersensitivity—Paclitaxel—ovarian cancer	0.002	0.00206	CcSEcCtD
Methyclothiazide—Constipation—Docetaxel—ovarian cancer	0.00197	0.00203	CcSEcCtD
Methyclothiazide—Asthenia—Paclitaxel—ovarian cancer	0.00195	0.002	CcSEcCtD
Methyclothiazide—SLC12A1—testis—ovarian cancer	0.00193	0.069	CbGeAlD
Methyclothiazide—Erythema multiforme—Doxorubicin—ovarian cancer	0.00191	0.00197	CcSEcCtD
Methyclothiazide—Malnutrition—Epirubicin—ovarian cancer	0.0019	0.00196	CcSEcCtD
Methyclothiazide—Diarrhoea—Paclitaxel—ovarian cancer	0.00186	0.00191	CcSEcCtD
Methyclothiazide—Muscle spasms—Epirubicin—ovarian cancer	0.00183	0.00188	CcSEcCtD
Methyclothiazide—Body temperature increased—Docetaxel—ovarian cancer	0.00182	0.00187	CcSEcCtD
Methyclothiazide—Dizziness—Paclitaxel—ovarian cancer	0.0018	0.00185	CcSEcCtD
Methyclothiazide—Vision blurred—Epirubicin—ovarian cancer	0.00179	0.00184	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—ovarian cancer	0.00176	0.00181	CcSEcCtD
Methyclothiazide—CA2—embryo—ovarian cancer	0.00176	0.0629	CbGeAlD
Methyclothiazide—Agitation—Epirubicin—ovarian cancer	0.00175	0.0018	CcSEcCtD
Methyclothiazide—Vomiting—Paclitaxel—ovarian cancer	0.00173	0.00178	CcSEcCtD
Methyclothiazide—Rash—Paclitaxel—ovarian cancer	0.00171	0.00176	CcSEcCtD
Methyclothiazide—Dermatitis—Paclitaxel—ovarian cancer	0.00171	0.00176	CcSEcCtD
Methyclothiazide—Vertigo—Epirubicin—ovarian cancer	0.00171	0.00176	CcSEcCtD
Methyclothiazide—Leukopenia—Epirubicin—ovarian cancer	0.0017	0.00175	CcSEcCtD
Methyclothiazide—Headache—Paclitaxel—ovarian cancer	0.0017	0.00175	CcSEcCtD
Methyclothiazide—Hypersensitivity—Docetaxel—ovarian cancer	0.0017	0.00174	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—ovarian cancer	0.00169	0.00174	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—ovarian cancer	0.00166	0.00171	CcSEcCtD
Methyclothiazide—Asthenia—Docetaxel—ovarian cancer	0.00165	0.0017	CcSEcCtD
Methyclothiazide—CA1—female reproductive system—ovarian cancer	0.00164	0.0589	CbGeAlD
Methyclothiazide—Agitation—Doxorubicin—ovarian cancer	0.00162	0.00166	CcSEcCtD
Methyclothiazide—Nausea—Paclitaxel—ovarian cancer	0.00161	0.00166	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—ovarian cancer	0.00158	0.00163	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—ovarian cancer	0.00158	0.00162	CcSEcCtD
Methyclothiazide—Diarrhoea—Docetaxel—ovarian cancer	0.00158	0.00162	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Epirubicin—ovarian cancer	0.00155	0.0016	CcSEcCtD
Methyclothiazide—CA1—bone marrow—ovarian cancer	0.00155	0.0556	CbGeAlD
Methyclothiazide—Dizziness—Docetaxel—ovarian cancer	0.00152	0.00157	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Epirubicin—ovarian cancer	0.00152	0.00156	CcSEcCtD
Methyclothiazide—Anorexia—Epirubicin—ovarian cancer	0.00148	0.00152	CcSEcCtD
Methyclothiazide—Vomiting—Docetaxel—ovarian cancer	0.00146	0.00151	CcSEcCtD
Methyclothiazide—Rash—Docetaxel—ovarian cancer	0.00145	0.00149	CcSEcCtD
Methyclothiazide—Dermatitis—Docetaxel—ovarian cancer	0.00145	0.00149	CcSEcCtD
Methyclothiazide—Headache—Docetaxel—ovarian cancer	0.00144	0.00148	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00144	0.00148	CcSEcCtD
Methyclothiazide—CA2—epithelium—ovarian cancer	0.00143	0.0514	CbGeAlD
Methyclothiazide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00141	0.00145	CcSEcCtD
Methyclothiazide—Paraesthesia—Epirubicin—ovarian cancer	0.00139	0.00143	CcSEcCtD
Methyclothiazide—Anorexia—Doxorubicin—ovarian cancer	0.00137	0.00141	CcSEcCtD
Methyclothiazide—Nausea—Docetaxel—ovarian cancer	0.00137	0.00141	CcSEcCtD
Methyclothiazide—CA2—decidua—ovarian cancer	0.00136	0.0485	CbGeAlD
Methyclothiazide—Decreased appetite—Epirubicin—ovarian cancer	0.00135	0.00139	CcSEcCtD
Methyclothiazide—Constipation—Epirubicin—ovarian cancer	0.00133	0.00137	CcSEcCtD
Methyclothiazide—Paraesthesia—Doxorubicin—ovarian cancer	0.00129	0.00133	CcSEcCtD
Methyclothiazide—CA4—female reproductive system—ovarian cancer	0.00129	0.046	CbGeAlD
Methyclothiazide—Decreased appetite—Doxorubicin—ovarian cancer	0.00125	0.00128	CcSEcCtD
Methyclothiazide—Urticaria—Epirubicin—ovarian cancer	0.00123	0.00127	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—ovarian cancer	0.00123	0.00126	CcSEcCtD
Methyclothiazide—Body temperature increased—Epirubicin—ovarian cancer	0.00123	0.00126	CcSEcCtD
Methyclothiazide—CA4—bone marrow—ovarian cancer	0.00121	0.0434	CbGeAlD
Methyclothiazide—CA4—female gonad—ovarian cancer	0.00117	0.0419	CbGeAlD
Methyclothiazide—Hypersensitivity—Epirubicin—ovarian cancer	0.00114	0.00118	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—ovarian cancer	0.00114	0.00117	CcSEcCtD
Methyclothiazide—Body temperature increased—Doxorubicin—ovarian cancer	0.00114	0.00117	CcSEcCtD
Methyclothiazide—Asthenia—Epirubicin—ovarian cancer	0.00111	0.00115	CcSEcCtD
Methyclothiazide—CA2—female reproductive system—ovarian cancer	0.00107	0.0382	CbGeAlD
Methyclothiazide—Diarrhoea—Epirubicin—ovarian cancer	0.00106	0.00109	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—ovarian cancer	0.00106	0.00109	CcSEcCtD
Methyclothiazide—CA4—testis—ovarian cancer	0.00104	0.0371	CbGeAlD
Methyclothiazide—Asthenia—Doxorubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Methyclothiazide—Dizziness—Epirubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Methyclothiazide—CA2—bone marrow—ovarian cancer	0.00101	0.036	CbGeAlD
Methyclothiazide—Vomiting—Epirubicin—ovarian cancer	0.000987	0.00102	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—ovarian cancer	0.000983	0.00101	CcSEcCtD
Methyclothiazide—Rash—Epirubicin—ovarian cancer	0.000979	0.00101	CcSEcCtD
Methyclothiazide—Dermatitis—Epirubicin—ovarian cancer	0.000978	0.00101	CcSEcCtD
Methyclothiazide—Headache—Epirubicin—ovarian cancer	0.000973	0.001	CcSEcCtD
Methyclothiazide—CA2—female gonad—ovarian cancer	0.00097	0.0347	CbGeAlD
Methyclothiazide—CA2—vagina—ovarian cancer	0.000964	0.0345	CbGeAlD
Methyclothiazide—CA1—lymph node—ovarian cancer	0.000962	0.0344	CbGeAlD
Methyclothiazide—Dizziness—Doxorubicin—ovarian cancer	0.00095	0.000977	CcSEcCtD
Methyclothiazide—Nausea—Epirubicin—ovarian cancer	0.000922	0.000949	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—ovarian cancer	0.000913	0.00094	CcSEcCtD
Methyclothiazide—Rash—Doxorubicin—ovarian cancer	0.000906	0.000932	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—ovarian cancer	0.000905	0.000931	CcSEcCtD
Methyclothiazide—Headache—Doxorubicin—ovarian cancer	0.0009	0.000926	CcSEcCtD
Methyclothiazide—CA2—testis—ovarian cancer	0.00086	0.0308	CbGeAlD
Methyclothiazide—Nausea—Doxorubicin—ovarian cancer	0.000853	0.000878	CcSEcCtD
Methyclothiazide—CA4—lymph node—ovarian cancer	0.000752	0.0269	CbGeAlD
Methyclothiazide—CA2—lymph node—ovarian cancer	0.000623	0.0223	CbGeAlD
